What is MedPharmics?
MedPharmics operates as a specialized, physician-owned clinical research organization headquartered in the Greater New Orleans Metro Area. The firm distinguishes itself through a consortium of board-certified physicians across multiple medical specialties, ensuring a high degree of clinical rigor and expertise. Under the leadership of Dr. Robert Jeanfreau, a Certified Principal Investigator, the company manages both inpatient and outpatient studies with a focus on patient-centric research. By utilizing proprietary databases of patients with established medical histories, MedPharmics provides a unique advantage in enrollment efficiency and protocol adherence, positioning itself as a critical partner for sponsors seeking excellence in clinical trial execution.
How much funding has MedPharmics raised?
MedPharmics has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in MedPharmics
PPP
Public-Private Partnership
What's next for MedPharmics?
Looking ahead, the strategic deployment of this capital will likely focus on scaling the company's infrastructure to accommodate a broader range of therapeutic areas and more complex trial designs. As the clinical research industry faces increasing pressure for faster, more accurate data, MedPharmics is poised to leverage its physician-led consortium to enhance its enrollment strategies and operational throughput. The firm's commitment to maintaining high standards of medical oversight will remain a cornerstone of its growth strategy, as it seeks to attract larger, multi-center trials. By optimizing its internal processes and expanding its reach, MedPharmics is set to play an increasingly vital role in the advancement of medical science and the development of next-generation therapies.
See full MedPharmics company page
